Cann Group Ltd (CAN) - Total Assets
Based on the latest financial reports, Cann Group Ltd (CAN) holds total assets worth AU$78.79 Million AUD (≈ $55.75 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See CAN book value for net asset value and shareholders' equity analysis.
Cann Group Ltd - Total Assets Trend (2015–2025)
This chart illustrates how Cann Group Ltd's total assets have evolved over time, based on quarterly financial data.
Cann Group Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Cann Group Ltd's total assets of AU$78.79 Million consist of 12.2% current assets and 87.9% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$10.00K | 0.0% |
| Accounts Receivable | AU$587.00K | 0.8% |
| Inventory | AU$4.34 Million | 5.5% |
| Property, Plant & Equipment | AU$69.17 Million | 87.8% |
| Intangible Assets | AU$9.00K | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how Cann Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CAN market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cann Group Ltd's current assets represent 12.2% of total assets in 2025, a decrease from 76.4% in 2015.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, down from 62.1% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is property, plant & equipment at 87.8% of total assets.
Cann Group Ltd Competitors by Total Assets
Key competitors of Cann Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $5.76 Million |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277
|
China | CN¥1.77 Billion |
Cann Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.12 | 0.21 | 1.93 |
| Quick Ratio | 0.06 | 0.08 | 0.38 |
| Cash Ratio | 0.00 | 0.02 | 0.24 |
| Working Capital | AU$-71.34 Million | AU$-61.98 Million | AU$6.04 Million |
Cann Group Ltd - Advanced Valuation Insights
This section examines the relationship between Cann Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.42 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -15.1% |
| Total Assets | AU$78.79 Million |
| Market Capitalization | $5.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cann Group Ltd's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Cann Group Ltd's assets decreased by 15.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cann Group Ltd (2015–2025)
The table below shows the annual total assets of Cann Group Ltd from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$78.79 Million ≈ $55.75 Million |
-15.07% |
| 2024-06-30 | AU$92.77 Million ≈ $65.64 Million |
-28.34% |
| 2023-06-30 | AU$129.47 Million ≈ $91.61 Million |
-7.30% |
| 2022-06-30 | AU$139.66 Million ≈ $98.82 Million |
+37.20% |
| 2021-06-30 | AU$101.79 Million ≈ $72.02 Million |
+33.23% |
| 2020-06-30 | AU$76.40 Million ≈ $54.06 Million |
-6.96% |
| 2019-06-30 | AU$82.11 Million ≈ $58.10 Million |
-5.40% |
| 2018-06-30 | AU$86.80 Million ≈ $61.42 Million |
+475.83% |
| 2017-06-30 | AU$15.07 Million ≈ $10.67 Million |
-5.16% |
| 2016-12-31 | AU$15.89 Million ≈ $11.25 Million |
+749.38% |
| 2016-06-30 | AU$1.87 Million ≈ $1.32 Million |
+157.70% |
| 2015-06-30 | AU$726.15K ≈ $513.80K |
-- |
About Cann Group Ltd
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.